Use of Tranexamic Acid for the Treatment of Mittelschmerz in a Patient with Type 1 von Willebrand Disease and Recurrent Hemorrhagic Cysts

J Obstet Gynaecol Can. 2020 Nov;42(11):1385-1387. doi: 10.1016/j.jogc.2020.02.128. Epub 2020 Mar 24.

Abstract

Background: Tranexamic acid reduces blood loss in patients with bleeding diatheses and is used in a number of gynaecologic and non-gynaecologic conditions CASE: We discuss the case of a 27-year-old woman with type 1 von Willebrand disease, who presented with a two-year history of severe mittelschmerz secondary to recurrent hemorrhagic cysts. The patient refused oral contraception and reported that traditional analgesia did not significantly alleviate symptoms. We theorized that the underlying von Willebrand disease compounded the degree of hemorrhage into her recurrent cysts. As such, a trial of mid-cycle tranexamic acid was offered, which drastically improved her symptoms.

Conclusion: We report that the use of mid-cycle tranexamic acid in patients with recurrent haemorrhagic cysts can lower ovulation-associated pain.

Keywords: ovarian cysts; tranexamic acid; von Willebrand disease, type 1.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cysts*
  • Female
  • Hemorrhage*
  • Humans
  • Ovulation
  • Pain / diagnosis
  • Pain / etiology*
  • Pelvic Pain / etiology*
  • Tranexamic Acid / therapeutic use*
  • Treatment Outcome
  • von Willebrand Disease, Type 1 / complications*
  • von Willebrand Disease, Type 1 / drug therapy
  • von Willebrand Diseases

Substances

  • Tranexamic Acid